Oxygenta Pharmaceutical Board of Directors
Get the latest insights into the leadership at Oxygenta Pharmaceutical. Learn about the experienced professionals guiding the company's strategy and governance.
| Name | Position |
|---|---|
| Mr. Balasubba Reddy Mamilla | Executive Director |
| Mr. Chandra Mouliswar Reddy Gangavaram | Executive Director |
| Mrs. Vedavathi Gangavaram | Non Exe.Non Ind.Director |
| Mr. Sidda Reddy Kanuparthi | Ind. Non-Executive Director |
| Mr. Veera Reddy Arava | Ind. Non-Executive Director |
| Mrs. Sharvari Swapnil Shinde | Ind. Non-Executive Director |
Oxygenta Pharmaceutical Share price
OXYGENTAPH
71
0.98 (1.40%)Last updated on 24 Sep, 2025 | 15:41 IST
BUYSELL
Today's High
72.37
Today's Low
67.55
52 Week Low
51.50
52 Week High
133.50
The current prices are delayed, login to your account for live prices
LoginOxygenta Pharmaceutical FAQs
The board at Oxygenta Pharmaceutical consists of experienced professionals, including Mr. Balasubba Reddy Mamilla , Mr. Chandra Mouliswar Reddy Gangavaram , and others, overseeing the company’s strategic and corporate governance.
Directors at Oxygenta Pharmaceutical are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.
As of the latest update, Mr. Balasubba Reddy Mamilla is the current chairman at Oxygenta Pharmaceutical.
Executive directors at Oxygenta Pharmaceutical are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.
Yes, Oxygenta Pharmaceutical adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.
At Oxygenta Pharmaceutical, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.